5579 |
PROTEIN KINASE C BETA |
PRKCB |
PKC-beta |
PKCB |
PRKCB1 |
PRKCB2 |
176970 |
9395 |
ENSG00000166501 |
OTTHUMG00000131615 |
PKC-B |
Protein kinase C beta type |
PROTEIN KINASE C, BETA TYPE (EC 2.7.1.37) (PKC-BETA) (PKC-B). [SOURCE:UNIPROT/SWISSPROT;ACC:P05771] |
PKC |
P05771 |
KPCB_HUMAN |
PA33761 |
T40276 |
PKCI(2) |
PKCbeta |
Human Readable Name | DRUGGABLE GENOME |
Interpro Acc | IPR002290 |
Uniprot Status | Swiss-Prot |
Human Readable Name | KINASE |
Interpro Name | Serine/threonine- / dual-specificity protein kinase, catalytic domain |
Interpro Type | Domain |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Short Name | Ser/Thr_dual-sp_kinase_dom |
Initial Gene Query | PKC beta |
Counted Citations from 1950-2000 | 908 |
Target Class | Enzymes |
Target Subclass | EC:2.7.11.13 |
Gene Biotype | PROTEIN_CODING |
TRANSPORTER |
KINASE |
SERINE THREONINE KINASE |
DRUGGABLE GENOME |
CLINICALLY ACTIONABLE |
inhibitor (inhibitory) |
Mechanism of Interaction | Protein kinase C beta inhibitor |
Direct Interaction | yes |
Trial Name | ruboxistaurin mesylate, LY 333531,Arxxant |
inhibitor (inhibitory) |
Mechanism of Interaction | Protein kinase C beta inhibitor |
Direct Interaction | yes |
Notes |
n/a |
Trial Name | Bryostatin |
Novel drug target | Established target |
inhibitor (inhibitory) |
Mechanism of Interaction | Protein kinase C (PKC) inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Protein kinase C (PKC) inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Protein kinase C (PKC) inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Protein kinase C (PKC) inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Protein kinase C (PKC) inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
PRKCB | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
PROTEIN KINASE C, BETA TYPE (EC 2.7.1.37) (PKC-BETA) (PKC-B). [SOURCE:UNIPROT/SWISSPROT;ACC:P05771] | Description |
ENSG00000166501 | Ensembl Gene Id |
PRKCB1 | Display Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
PRKCB | Gene Symbol |
PRKCB1 | Gene Symbol |
Target Class | Enzymes |
Target Subclass | EC:2.7.11.13 |
PRKCB | Uniprot Gene Name |
PROTEIN KINASE C BETA TYPE | Uniprot Protein Name |
KPCB_HUMAN | Uniprot Id |
Interpro Acc | IPR002290 |
Uniprot Status | Swiss-Prot |
Human Readable Name | DRUGGABLE GENOME |
KINASE, DRUGGABLE GENOME |
5579 | Entrez Gene ID |
Initial Gene Query | PKC beta |
Counted Citations from 1950-2000 | 908 |
KINASE |
ENSG00000166501 | Gene Symbol |
PRKCB | Ensembl Id |
DRUGGABLE GENOME |
PKCB | Gene Symbol |
5579 | Entrez Gene Id |
PRKCB | MyCancerGenome Gene Symbol |
PKC-beta | MyCancerGenome Reported Gene Name |
PRKCB1 | GENE_SYMBOL |
PRKCB | GENE_SYMBOL |
Protein kinase C beta type | UNIPROT |
PA33761 | PharmGKB ID |
PKCB | GO Gene Synonym |
PRKCB1 | GO Gene Synonym |
SERINE THREONINE KINASE |
5579 | Gene ID |
PKC-beta | dGene Synonym |
PKCB | dGene Synonym |
KINASE, SERINE THREONINE KINASE |
PRKCB | TTD Gene Abbreviation |
T40276 | TTD Target ID |
Protein kinase C beta type | Gene Name |
P05771 | UniProt ID |
TRANSPORTER, KINASE |
CLINICALLY ACTIONABLE |